SI1910288T1 - 3-aminokarbazolne spojine, farmacevtski sestavek, ki jih vsebuje, in postopek za njihovo pripravo - Google Patents

3-aminokarbazolne spojine, farmacevtski sestavek, ki jih vsebuje, in postopek za njihovo pripravo

Info

Publication number
SI1910288T1
SI1910288T1 SI200630776T SI200630776T SI1910288T1 SI 1910288 T1 SI1910288 T1 SI 1910288T1 SI 200630776 T SI200630776 T SI 200630776T SI 200630776 T SI200630776 T SI 200630776T SI 1910288 T1 SI1910288 T1 SI 1910288T1
Authority
SI
Slovenia
Prior art keywords
preparation
pharmaceutical composition
same
composition containing
aminocarbazole compounds
Prior art date
Application number
SI200630776T
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Patrizia Dragone
Guido Furlotti
Nicola Cazzolla
Vincenzo Russo
Giorgina Mangano
Isabella Coletta
Lorenzo Polenzani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of SI1910288T1 publication Critical patent/SI1910288T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200630776T 2005-08-03 2006-07-25 3-aminokarbazolne spojine, farmacevtski sestavek, ki jih vsebuje, in postopek za njihovo pripravo SI1910288T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001523A ITMI20051523A1 (it) 2005-08-03 2005-08-03 Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP06776431A EP1910288B1 (en) 2005-08-03 2006-07-25 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
PCT/EP2006/007393 WO2007014687A1 (en) 2005-08-03 2006-07-25 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof

Publications (1)

Publication Number Publication Date
SI1910288T1 true SI1910288T1 (sl) 2010-10-29

Family

ID=35501077

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630776T SI1910288T1 (sl) 2005-08-03 2006-07-25 3-aminokarbazolne spojine, farmacevtski sestavek, ki jih vsebuje, in postopek za njihovo pripravo

Country Status (24)

Country Link
US (2) US7879900B2 (sl)
EP (1) EP1910288B1 (sl)
JP (1) JP5274252B2 (sl)
KR (1) KR101278620B1 (sl)
CN (1) CN101223139B (sl)
AR (1) AR056014A1 (sl)
AT (1) ATE471930T1 (sl)
AU (1) AU2006275063B2 (sl)
BR (1) BRPI0615158A8 (sl)
CA (1) CA2609441C (sl)
DE (1) DE602006015062D1 (sl)
DK (1) DK1910288T3 (sl)
EA (1) EA012786B1 (sl)
ES (1) ES2345944T3 (sl)
GE (1) GEP20104964B (sl)
HK (1) HK1112916A1 (sl)
IL (1) IL187713A (sl)
IT (1) ITMI20051523A1 (sl)
MX (1) MX2008001551A (sl)
PL (1) PL1910288T3 (sl)
PT (1) PT1910288E (sl)
SI (1) SI1910288T1 (sl)
UA (1) UA93378C2 (sl)
WO (1) WO2007014687A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119705A1 (en) * 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
GB0812186D0 (en) 2008-07-03 2008-08-13 Dow Corning Modified polyolefins
GB0812185D0 (en) 2008-07-03 2008-08-13 Dow Corning Polymers modified by silanes
ATE547403T1 (de) 2008-08-15 2012-03-15 Univ Georgetown Fluoreszente regulatoren der rassf1a-expression und der proliferation humaner krebszellen
GB201000121D0 (en) 2010-01-06 2010-02-17 Dow Corning Modified polyolefins
GB201000120D0 (en) 2010-01-06 2010-02-17 Dow Corning Process for forming crosslinked and branched polymers
GB201000128D0 (en) 2010-01-06 2010-02-24 Dow Corning Modified polymers
GB201000117D0 (en) 2010-01-06 2010-02-17 Dow Corning Organopolysiloxanes containing an unsaturated group
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
MX2010014124A (es) * 2010-12-17 2012-06-18 Gabriel Diaz Hernandez Solución antiséptica local de amplio espectro a base de hipodorito de sodio, bicarbonato de sodio, cloramfenicol, jabón y solución salina al 0.9%.
FR2972193B1 (fr) 2011-03-04 2014-07-04 Setup Performance Polyolefines modifiees, reticulables apres transformation, et procede de fabrication desdites polyolefines
US10376672B2 (en) 2013-03-15 2019-08-13 Auris Health, Inc. Catheter insertion system and method of fabrication
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
WO2021195346A1 (en) * 2020-03-25 2021-09-30 Sri International Lipoxygenase inhibitors
CN112159345B (zh) * 2020-11-18 2023-08-25 湖北和昌新材料科技股份有限公司 N-乙基咔唑的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6399631B1 (en) * 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
WO2001007409A1 (en) 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
AU769081B2 (en) * 1999-08-26 2004-01-15 Bristol-Myers Squibb Company NPY antagonists: spiroisoquinolinone derivatives
BR0116388A (pt) 2000-12-22 2003-09-30 Astrazeneca Ab Composto, processo para preparar um composto, composição farmacêutica e método para tratar, em um animal de sangue quente, distúrbios de alimentação e uso de um composto
DE10125961A1 (de) 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ITMI20050909A1 (it) 2005-05-19 2006-11-20 Acraf Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Also Published As

Publication number Publication date
IL187713A (en) 2011-09-27
DK1910288T3 (da) 2010-10-11
EP1910288B1 (en) 2010-06-23
US8207214B2 (en) 2012-06-26
ITMI20051523A1 (it) 2007-02-04
EA012786B1 (ru) 2009-12-30
UA93378C2 (ru) 2011-02-10
IL187713A0 (en) 2008-08-07
ATE471930T1 (de) 2010-07-15
PT1910288E (pt) 2010-08-18
PL1910288T3 (pl) 2010-11-30
MX2008001551A (es) 2008-04-22
BRPI0615158A8 (pt) 2018-03-06
BRPI0615158A2 (pt) 2011-05-03
WO2007014687A1 (en) 2007-02-08
AR056014A1 (es) 2007-09-12
AU2006275063B2 (en) 2012-03-08
CA2609441A1 (en) 2007-02-08
ES2345944T3 (es) 2010-10-06
CA2609441C (en) 2013-09-03
EA200800502A1 (ru) 2008-06-30
CN101223139B (zh) 2010-11-17
DE602006015062D1 (de) 2010-08-05
HK1112916A1 (en) 2008-09-19
US20080207727A1 (en) 2008-08-28
KR101278620B1 (ko) 2013-06-25
EP1910288A1 (en) 2008-04-16
JP5274252B2 (ja) 2013-08-28
AU2006275063A1 (en) 2007-02-08
CN101223139A (zh) 2008-07-16
US7879900B2 (en) 2011-02-01
GEP20104964B (en) 2010-04-26
US20110046197A1 (en) 2011-02-24
KR20080040691A (ko) 2008-05-08
JP2009502999A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL225207A (en) A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
EP2114904A4 (en) TRIAZOLE DERIVATIVES WITH ANTIPILY EFFECT, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
HK1123789A1 (en) Azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
IL210756A0 (en) Carbostyril compound, process for their preparation and pharmaceutical compositions containing them
PL1752443T3 (pl) Nowa postać krystaliczna V agomelatyny, sposób jej wytwarzania i kompozycje farmaceutyczne, które ją zawierają
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP2201011A4 (en) NEW COMPOUNDS WITH INDAZOUS OUTS, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
IL186062A (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
PL2231598T3 (pl) Nowe pochodne diazeniodiolanów, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
HUP0401523A3 (en) Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
EP2035406A4 (en) NEW SUBSTITUTED 1H-CHINAZOLIN-2,4-DION DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
HK1096097A1 (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
ZA200902413B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds